Perinatal OCD is common but often missed by depression-only screens. Adding perinatal-specific anxiety and OCD tools can improve detection and guide targeted treatment.
Many women taking stimulants question whether it is safe to take these medications while breastfeeding. Â
How should psychiatrists think about hormone therapy in perimenopause? This article explains when, why, and how to consider MHT for perimenopausal women with mood and anxiety symptoms.
Current guidelines list gabapentin as a recommended nonhormonal therapy for vasomotor symptoms in women who cannot or prefer not to use hormone therapy.
According to a recent meta-analysis, about one out of every five women has at least one type of anxiety disorder during pregnancy or the postpartum period.
Prenatal exposure to valproate is linked to increased risk of autism spectrum disorder, ADHD, lower IQ, and intellectual disability, especially at higher doses.
Women with premenstrual mood disorders face significantly higher risk of suicidal ideation and behavior, highlighting the need for careful assessment and targeted prevention.
While many peri- and post-menopausal women request bioidentical hormones, there is no data to suggest that bioidential hormones are safer or more effective than FDA-approved hormone replacement therapies.
According to a recent meta-analysis, about one out of every five women has at least one type of anxiety disorder during pregnancy or the postpartum period.
Several studies suggest that screening during the first week postpartum may be helpful in identifying women at higher risk for experiencing postpartum depression.
